Characterizing the coverage of critical effects relevant in the safety evaluation of food additives by AOPs

Autor: Heinz Traussnig, Sara Levorato, Ivonne M.C.M. Rietjens, Siyao Wu, Natalie Thatcher, Mathieu Vinken, Y. Hoffmans, Anette Thiel, Stefan Schulte, Timothy E. H. Allen, Alan R. Boobis, Nynke I. Kramer
Přispěvatelé: Allen, Timothy [0000-0001-7369-0901], Apollo - University of Cambridge Repository, Liver Connexin and Pannexin Research Group, Pharmaceutical and Pharmacological Sciences, Connexin Signalling Research Group, Experimental in vitro toxicology and dermato-cosmetology
Rok vydání: 2019
Předmět:
Acceptable daily intake
food.ingredient
ADVERSE OUTCOME PATHWAYS
Food Safety
Novel Foods & Agrochains
STRATEGIES
BU Toxicologie
Health
Toxicology and Mutagenesis

Novel Foods & Agroketens
Toxicology
Kidney
Risk Assessment
Regulatory Toxicology
3Rs
food
Adverse outcome pathway
Environmental health
Adverse Outcome Pathway
Medicine
media_common.cataloged_instance
Humans
Gastrointestinal irritation
BU Toxicology
Novel Foods & Agrochains

European union
Adverse effect
Toxicologie
media_common
VLAG
No-Observed-Adverse-Effect Level
Science & Technology
IDENTIFICATION
business.industry
Food additive
BU Toxicology
Data interpretation
General Medicine
Food additives
BU Toxicologie
Novel Foods & Agroketens

Liver
Food Additives
1115 Pharmacology and Pharmaceutical Sciences
business
Risk assessment
Critical adverse effect
Life Sciences & Biomedicine
Zdroj: Archives of Toxicology, 93(8), 2115-2125
Archives of Toxicology 93 (2019) 8
ISSN: 0340-5761
Popis: There is considerable interest in adverse outcome pathways (AOPs) as a means of organizing biological and toxicological information to assist in data interpretation and method development. While several chemical sectors have shown considerable progress in applying this approach, this has not been the case in the food sector. In the present study, safety evaluation reports of food additives listed in Annex II of Regulation (EC) No 1333/2008 of the European Union were screened to qualitatively and quantitatively characterize toxicity induced in laboratory animals. The resulting database was used to identify the critical adverse effects used for risk assessment and to investigate whether food additives share common AOPs. Analysis of the database revealed that often such scrutiny of AOPs was not possible or necessary. For 69% of the food additives, the report did not document any adverse effects in studies based on which the safety evaluation was performed. For the remaining 31% of the 326 investigated food additives, critical adverse effects and related points of departure for establishing health-based guidance values could be identified. These mainly involved effects on the liver, kidney, cardiovascular system, lymphatic system, central nervous system and reproductive system. AOPs are available for many of these apical endpoints, albeit to different degrees of maturity. For other adverse outcomes pertinent to food additives, including gastrointestinal irritation and corrosion, AOPs are lacking. Efforts should focus on developing AOPs for these particular endpoints.
Databáze: OpenAIRE